Citius Pharmaceuticals Inc. (CTXR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Citius Pharmaceuticals In...

    NASDAQ: CTXR · Real-Time Price · USD
    1.37
    0.04 (3.01%)
    At close: Oct 03, 2025, 3:59 PM
    1.39
    1.46%
    After-hours: Oct 03, 2025, 07:20 PM EDT

    Citius Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    PE Ratio
    		 -3.71 -5.12 -8.76 -15.89
    PEG Ratio
    		 -0.52 1.55 -4.12 -0.01
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 2.07 1.84 2.87 2.78
    P/FCF Ratio
    		 -5.15 -5.74 -10.39 -5.72
    P/OCF Ratio
    		 -5.15 -5.74 -10.39 -15.15
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.00 0.01 0.01 0.01
    Quick Ratio
    		 0.17 5.95 9.84 18.28
    Current Ratio
    		 0.40 5.95 9.84 18.28
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -132.52 -2.17K
    Return on Equity
    		 -0.56 -0.36 -0.33 -0.17
    Return on Assets
    		 -0.34 -0.31 -0.3 -0.16
    Return on Invested Capital
    		 -0.53 -0.38 -0.31 -0.17
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist